InvestorsHub Logo
Followers 0
Posts 1151
Boards Moderated 0
Alias Born 07/10/2003

Re: None

Monday, 09/01/2003 7:56:51 AM

Monday, September 01, 2003 7:56:51 AM

Post# of 82595
On Matthew J. Thomas - The company is also pleased to announce that Matthew J. Thomas, Ph.D. will be joining the company as a Scientist from his post at the H. Lee Moffit Cancer Center, University of South Florida, Tampa, FL. Dr. Thomas obtained his Ph.D. in Biology from the Department of Biology and Institute of Molecular Biology, University of Oregon. He is the recipient of the competitive Leukemia Society of America Fellowship, and has published original molecular biology research in such prestigious journals as Cell, Oncogene, Gene and Nucleic Acids Research. The addition of Dr. Thomas will help increase the Companies data flow and analysis."

From the Leukemia and Lymphoma Society 2001 Annual Report: Research Grant recipient Matthew J.Thomas, PhD –1999 University of South Florida.

Yiwen He, Michael K Armanious, Matthew J Thomas & W Douglas Cress. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Oncogene 13 July 2000, Volume 19, Number 30.

Matthew J. Thomas, Angelina A. Platas, and Diane K. Hawley. Transcriptional Fidelity and Proofreading by RNA Polymerase II. Cell May 15, 1998: 93 (4).

Matthew J. Thomas, Edward Seto. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene Volume 236, Issue 2, Page 197-355 (20 August 1999).